September 2026
The global precision genomic testing market size is valued at USD 20.55 billion in 2026 and is expected to hit around USD 69.72 billion by 2035, growing at a CAGR of 14.57%.
June 2025
The consumer genomics market size was valued at USD 2.03 billion in 2024 and it is expected hit around USD 18.83 billion by 2034 with a CAGR of 24.95%.
September 2026
The global genomics in cancer care market size was evaluated at USD 28.32 billion in 2026 and is predicted to hit around USD 108.69 billion by 2035, growing at a CAGR of 28.32%.
September 2026
The global bioburden testing market size was estimated at USD 1.98 billion in 2026 and is projected to attain around USD 6.47 billion by 2035, with a CAGR of 13.03%.
September 2026
The global precision guided munition market size reached USD 46.93 billion in 2026 and is projected to hit around USD 82.62 billion by 2035, growing at a CAGR of 6.51%.
September 2026
The global non-oncology precision medicine market size is calculated at USD 101.25 billion in 2026 and is projected to hit around USD 222.95 billion by 2035 with a CAGR of 9.23%.
September 2026
The global precision farming market size is evaluated at USD 16.07 billion in 2026 and is projected to surpass around USD 48.36 billion by 2035 with a CAGR of 13.05%.
September 2026
The global neurogenomics market size was estimated at USD 2.34 billion in 2026 and is expected to hit around USD 9.06 billion by 2035, growing at a CAGR of 16.25% from 2026 to 2035.
September 2026
The global blood testing market size was estimated at USD 121.51 billion in 2026 and is projected to hit around USD 224.14 billion by 2035 with a notable CAGR of 7.06%.
September 2026
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
September 2026
The precision diagnostics market size was estimated at USD 109.84 billion in 2026, with precision diagnostics market Companies Abbott Laboratories, Bayer AG, Koninklijke Philips N.V., Lantheus Holdings Inc.
September 2026
The personalized testing and supplements market size reached USD 5.61 billion in 2026, with leading personalized testing and supplements market companies including Viome Life Sciences, DSM Nutritional Products AG.
September 2026
The global adiponectin testing market size was evaluated at USD 60.56 billion in 2026 and is predicted to hit around USD 120.35 billion by 2035, growing at a CAGR of 7.93%.
September 2026
The global animal testing and ecotoxicology testing market was valued at USD 4,925.33 million in 2025. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The global extractable and leachable (E&L) testing services market was valued at USD 1,113.69 million in 2025 and is expected to expand at a CAGR of 12.74% during the forecast period. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The preclinical bioanalytical testing services market was valued at USD 1.18 billion in 2025 and is expected to expand at a CAGR of 10.80% from 2026 to 2035. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The global precision dermatology market is poised for significant growth as personalized skin therapies and diagnostics drive demand in the dermatology sector.
September 2026
The global endotoxin testing market size is expected to increase from USD 1.60 billion in 2026 to hit around USD 3.78 billion by 2035, growing at a CAGR of 10.05%.
September 2026
The artificial intelligence in genomics market size is projected to hit around USD 25,860.87 million by 2035 from USD 1,503.86 million in 2026 with a CAGR of 37.3%.
September 2026
The global diagnostic testing market size reached USD 213.03 billion in 2026 and is projected to hit around USD 281.56 billion by 2035, growing at a CAGR of 3.08%.
September 2026
The global precision gearbox market size is calculated at USD 5.46 billion in 2026 and is projected to hit around USD 11.65 billion by 2035 with a CAGR of 8.78%.
September 2026
The global esoteric testing market size is estimated at USD 41.05 billion in 2026 and is predicted to hit around USD 100.94 billion by 2035 with a CAGR of 10.53%.
September 2026
The global pharmacogenomics market size is projected to hit around USD 46.29 billion by 2035 from USD 21.41 billion in 2025 and expand at a CAGR of 8.98%.
September 2026
The global endocrine testing market size was estimated at USD 16.97 billion in 2026 and is expected to surge around USD 35.43 billion by 2035 with a CAGR of 8.53%
September 2026
The global single-cell genomics market is growing as advanced sequencing technologies enable high-resolution analysis of individual cells.
September 2026
The non-invasive prenatal testing market size was USD 8.05 billion in 2026, with leading non-invasive prenatal testing market players including Genesis Genetics, Natera, Centogene, Eurofins LifeCodexx GmbH.
September 2026
The global toxicology testing services market size is estimated to surpass around USD 70.78 billion by 2035 from USD 43.55 billion in 2026, with a CAGR of 5.55%.
September 2026
The non-destructive testing (NDT) market size accounted for USD 24.59 billion in 2025 and is expected to hit around USD 56.23 billion by 2035 with a CAGR of 9.69%.
September 2026
The global noise vibration and harshness testing market size is estimated to hit around USD 4.62 billion by 2034 increasing from USD 2.84 billion in 2026, at a CAGR of 6.30%.
September 2026
The precision reduction gears market was valued at USD 3.34 billion in 2026, with leading companies including Harmonic Drive Systems Inc., Nabtesco Corporation, Sumitomo Heavy Industries.